Cipla Limited (CIPLA.NS)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic
1,415.00 INR-0.25%As of 2026-11-22 · INR
Last session low 1,401.20 INRLast session high 1,428.00 INR
52-week low 1,165.70 INR52-week high 1,539.70 INR
Market cap (USD)
$12.34B
Sector
Healthcare
P/E (TTM)
39.5x
Dividend yield
0.92%
Next earnings
2027-01-21 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in INR.

IndicatorValueReading
RSI (14)61.5In the neutral range (30 to 70)
MACD (12, 26, 9)14.50Above its signal line (12.31); histogram 2.20
Bollinger %B (20, 2)76%Inside the bands (1,341.88 to 1,437.93)
SMA 201,389.90Price is 1.8% above
SMA 501,367.15Price is 3.5% above
SMA 2001,360.29Price is 4.0% above
ATR (20)1.80% of priceAverage true range per day
52-week position67%In the middle of the 1,165.70 to 1,539.70 range

About Cipla Limited

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Latest fiscal yearEnded 2026-03-31: revenue of 277.12B INR and an operating margin of 17.5%.
Next earnings reportExpected on 2027-01-21 (the date is an estimate).

More in Drug Manufacturers - Specialty & Generic